2017 Interviews

Developing Competitive Biologics Products Necessitates Combining Formulation Design, Process Development, and Device Integration

Yatin Gokarn, Ph.D., Head, Global Pharmaceutical Development Biologics, Sanofi Genzym

Mario Lebendiker, Ph.D., Head, Protein Purification Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem

There is an increasing need for designing and developing competitive biologics drug products in biotherapeutics marketplace when many new modalities and new product formats are making their way to market and many promising leads continue to fill the research and development pipelines. A competitive patient-centric product necessitates a holistic product development strategy that takes into consideration formulation design, process development, analytics and device integration.
View the Interview

Translating Protein Expression Research to Biotech Startup Success and Bioprocess Goals

Tsafi Danieli, Ph.D., Director, BioGiv Excubator & Head, Protein Expression Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem

Mario Lebendiker, Ph.D., Head, Protein Purification Facility, Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem

Cambridge Healthtech Institute’s Ann Nguyen recently interviewed Tsafi Danieli, Ph.D. and Mario Lebendiker, Ph.D., Heads of the Protein Expression Facility and Protein Purification Facility, respectively, at Wolfson Centre for Applied Structural Biology, Alexander Silberman Institute of Life Sciences, The Hebrew University of Jerusalem. They will instruct their upcoming training seminar on Basic Technologies in a Protein Production Lab August 21-22 at The Bioprocessing Summit in Boston.
View the Interview

Phase Appropriate Analytical Characterization of Recombinant Protein Based Vaccines

Vaneet K. Sharma, Ph.D., Analytical Scientist, Vaccine Development & Manufacturing,International AIDS Vaccine Initiative (IAVI)

Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. Vaneet Sharma, an Analytical Scientist in the Vaccine Development & Manufacturing group of International AIDS Vaccine Initiative (IAVI), about his upcoming presentation “Phase Appropriate Analytical Characterization of Recombinant Protein Based Vaccines”, to be delivered at the Early Analytical Development for Biotherapeutics meeting being held as part of The Bioprocessing Summit in Boston.
View the Interview

Industry Approaches to Facility Segregation for Viral Safety

Paul Barone, Associate Director, BioMAN and CAACB, MIT Center for Biomedical Innovation

Cambridge Healthtech Institute recently spoke with Dr. Paul Barone of Massachusetts Institute of Technology about Viral Safety and where the field and industry is headed in coming years. Dr. Barone is a speaker at the 3rd Annual Virus and Pathogen Clearance and Safety in Biologics which is taking place from August 24-25, 2017 in Boston, MA where he will be delivering his talk on “Industry Approaches to Facility Segregation for Viral Safety”. This conference is being organized as part of The Bioprocessing Summit which runs from August 21-25.
View the Interview

Data Management in Process Development as a Key to Process Understanding and Development Efficiency

Martin Mayer, Ph.D., Director, evon GmbH, Austria

Cambridge Healthtech Institute’s Kent Simmons recently spoke with Dr. Martin Mayer, a Director with Austria’s evon GmbH, Austria, about his upcoming presentation “Data Management in Process Development as a Key to Process Understanding and Development Efficiency”, to be delivered in the Process Characterization and Control meeting at the 2017 Bioprocessing Summit. The Summit is scheduled for August 21-25 at the Westin Copley Place hotel in Boston, with the process charactertization program set for August 24-25.
View the Interview

Interviews

Epigenetic Effects on Antibody Production in CHO Cells

Susan Sharfstein, Ph.D., Associate Professor, Nanobioscience, Nanoscale Science and Engineering, SUNY Polytechnic Institute

Dr. Susan Sharfstein, Associate Professor of Nanoscale Science and Engineering at SUNY Polytechnic Institute, and a speaker at the upcoming Optimizing Cell Line Development conference shares insight on her presentation "Epigenetic Effects on Antibody Production in CHO Cells".
View the Interview

Optimization, Simplification and Intensification of Cell Culture Processes

Jochen_SieckJochen B. Sieck, Ph.D., Lab Head, Cell Culture Media R&D, Process Solutions R&D, Merck KGaA

Dr. Jochen B. Sieck, Lab Head of Cell Culture Media R&D, Process Solutions R&D, at Merck KGaA shares insight on his presentation "Optimization, Simplification and Intensification of Cell Culture Processes" to be featured at the upcoming Optimizing Cell Culture Technology conference being held in Boston.
View the Interview

Plant-Wide Process Control Model for Biological Manufacturing

Richard D. Braatz is the Edwin R. Gilliland Professor of Chemical Engineering at MIT.

Cambridge Healthtech Institute’s Kent Simmons recently spoke with Richard D. Braatz about his upcoming presentation “Plant-Wide Process Control Model for Biological Manufacturing,” to be held August 19 in Boston as part of the Process Characterization, Qualification and Control conference at the 8th Annual Bioprocessing Summit.
View the Interview | Download the PDF

Harmonizing Transient and Stable CHO Expression Platforms for Early-Phase Drug Discovery

Dr. Yashas Rajendra, Research Scientist of Bio-TDR Cell Culture at Eli Lilly and Company

Dr. Yashas Rajendra, Research Scientist of Bio-TDR Cell Culture at Eli Lilly and Company, and a speaker at the upcoming "Optimizing Cell Culture Technology Conference" shares insight on streamlining the discovery process by minimizing the risk when molecules move forward in the portfolio.
View the Interview | Download the PDF

OutlookYouTubeFacebookLinkedInTwitter #BPSMT